CHICAGO EQUITY PARTNERS LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 191 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$413,000
-59.4%
34,145
-52.5%
0.02%
-50.0%
Q3 2019$1,016,000
+464.4%
71,855
+345.1%
0.05%
+500.0%
Q2 2019$180,000
-91.9%
16,145
-86.9%
0.01%
-88.2%
Q4 2017$2,222,000
-15.8%
123,010
-10.1%
0.07%
-18.1%
Q3 2017$2,640,000
+197.6%
136,780
+82.0%
0.08%
+245.8%
Q2 2017$887,000
+48.6%
75,165
+38.1%
0.02%
+41.2%
Q1 2017$597,000
+58.8%
54,435
+5.2%
0.02%
+70.0%
Q4 2016$376,000
-7.2%
51,755
-16.9%
0.01%
-9.1%
Q3 2016$405,00062,2950.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,188,417$85,349,0007.80%
TANAKA CAPITAL MANAGEMENT INC 144,602$2,379,0005.69%
INGALLS & SNYDER LLC 6,817,540$112,149,0005.47%
NEXTHERA CAPITAL LP 1,045,196$17,193,0002.83%
Timpani Capital Management LLC 245,279$4,035,0001.41%
S&T BANK/PA 426,257$7,012,0001.25%
SHAKER INVESTMENTS LLC/OH 107,670$1,771,0001.10%
ESSEX INVESTMENT MANAGEMENT CO LLC 434,624$7,150,0000.94%
AMI ASSET MANAGEMENT CORP 709,300$11,668,0000.83%
Birchview Capital, LP 75,500$1,242,0000.82%
View complete list of CORCEPT THERAPEUTICS INC shareholders